Laurence Lodé, Audrey Ménard, Laurent Flet, Steven Richebourg, Marion Loirat, Marion Eveillard, Yannick Le Bris, Catherine Godon, Olivier Theisen, Anne-Laure Gagez, Guillaume Cartron, Thérèse Commes-Maerten, Bruno Villemagne, Odile Luycx, Pascal Godmer, Catherine Pellat-Deceunynck, Thierry Soussi, Marie C. Béné, Jacques Delaunay, and Pierre Peterlin. 2018. “Emergence and Evolution of TP53 Mutations Are Key Features of Disease Progression in Myelodysplastic Patients With Lower-Risk del(5q) Treated With Lenalidomide”. Haematologica 103 (4). Pavia, Italy, e143-e146. https://doi.org/10.3324/haematol.2017.181404.